Emerging drugs for the management of cancer treatment induced bone loss
Author:
Publisher
Informa Healthcare
Subject
Pharmacology (medical),Pharmacology
Link
http://www.tandfonline.com/doi/pdf/10.1517/14728211003631385
Reference168 articles.
1. Osteoporosis Due to Cancer Treatment: Pathogenesis and Management
2. Osteoporosis in women with breast cancer
3. Therapy Insight: osteoporosis during hormone therapy for prostate cancer
4. Low bone mineral density in hormone-na�ve men with prostate carcinoma
5. Immediate dual energy X-ray absorptiometry reveals a high incidence of osteoporosis in patients with advanced prostate cancer before hormonal manipulation
Cited by 9 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Nutlin-3 treatment spares cisplatin-induced inhibition of bone healing while maintaining osteosarcoma toxicity;Journal of Orthopaedic Research;2016-02-26
2. Cisplatin inhibits bone healing during distraction osteogenesis;Journal of Orthopaedic Research;2013-11-20
3. Gene Expression Signatures That Predict Outcome of Tamoxifen-Treated Estrogen Receptor-Positive, High-Risk, Primary Breast Cancer Patients: A DBCG Study;PLoS ONE;2013-01-16
4. The Italian cross-sectional survey of the management of bone metastasis: ZeTa study;Journal of Bone Oncology;2012-09
5. Aromatase inhibitor-associated bone loss and its management with bisphosphonates in patients with breast cancer;Breast Cancer: Targets and Therapy;2012-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3